Published on 1 Mar 2023 on Benzinga via Yahoo Finance
Novavax Ushers New CEO On Uncertainty Concerns, Says It Needs To Work On Competitive COVID-19...
COVID-19 vaccine maker Novavax Inc (NASDAQ: NVAX) shares plunged after it raised doubts about its ability to remain in business and announced plans to cut spending.
The company said significant uncertainty exists around its 2023 revenue, funding from the U.S. government, and pending arbitration with the global vaccine alliance.